STAT3-IN-19

STAT3-IN-19 is an orally active and selective STAT3 inhibitor. STAT3-IN-19 inhibits STAT3 Tyr705 phosphorylation, downregulates the expression of downstream Cyclin D1, Bcl‑xL, and survivin target genes, inhibits colorectal cancer cell proliferation, migration, and sphere formation, and induces apoptosis. STAT3-IN-19 exhibits antitumor efficacy in colorectal cancer xenograft models and synergizes with Capecitabine (HY-B0016) to inhibit colorectal tumor growth. STAT3-IN-19 can be used for research on colorectal cancer.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • 화학식: C17H13N3O3S
  • 분자량:339.37
  • 보관:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocol
  • 순도&문서
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

견적 받기 해외재고보유

Other size
견적 받기
Please select quantity
Amount: USD 0.00